Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Pol

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Journal for Immunotherapy of Cancer|March 30, 2020
Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapyYan Wang, Wei Xie, Juliette Humeau, et al.
Oncoimmunology|February 7, 2019
Anticancer effects of anti-CD47 immunotherapy <i>in vivo</i>Kristina Iribarren, Aitziber Buque, Laura Mondragon, et al.
Oncoimmunology|December 8, 2018
Trial watch: Peptide-based vaccines in anticancer therapyLucillia Bezu, Oliver Kepp, Giulia Cerrato, et al.
Oncoimmunology|October 2, 2013
Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8<sup>+</sup> T-cell responses to anticancer vaccinesByram W Bridle, Derek Clouthier, Liang Zhang, et al.
Oncoimmunology|May 6, 2015
Trial Watch: Radioimmunotherapy for oncological indicationsNorma Bloy, Jonathan Pol, Gwenola Manic, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 5, 2024
Isolation of Primary Mouse Hepatocytes and Non-Parenchymal Cells from a Liver with Precancerous LesionsFlavia Lambertucci, Omar Motiño, Maria Pérez-Lanzón, et al.
Autophagy|August 18, 2016
Autophagy induction for the treatment of cancerFederico Pietrocola, Jonathan Pol, Erika Vacchelli, et al.
Oncoimmunology|May 7, 2014
Trial Watch: DNA vaccines for cancer therapyJonathan Pol, Norma Bloy, Florine Obrist, et al.
The Journal of Infectious Diseases|June 6, 2008
Expression of defective hepatitis B virus particles derived from singly spliced RNA is related to liver diseasePatrick Soussan, Jonathan Pol, Florianne Garreau, et al.
Cell Reports|July 19, 2018
HDACi Delivery Reprograms Tumor-Infiltrating Myeloid Cells to Eliminate Antigen-Loss VariantsAndrew Nguyen, Louisa Ho, Samuel T Workenhe, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Journal for Immunotherapy of Cancer|March 30, 2020
Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapyYan Wang, Wei Xie, Juliette Humeau, et al.
Oncoimmunology|February 7, 2019
Anticancer effects of anti-CD47 immunotherapy <i>in vivo</i>Kristina Iribarren, Aitziber Buque, Laura Mondragon, et al.
Oncoimmunology|December 8, 2018
Trial watch: Peptide-based vaccines in anticancer therapyLucillia Bezu, Oliver Kepp, Giulia Cerrato, et al.
Oncoimmunology|October 2, 2013
Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8<sup>+</sup> T-cell responses to anticancer vaccinesByram W Bridle, Derek Clouthier, Liang Zhang, et al.
Oncoimmunology|May 6, 2015
Trial Watch: Radioimmunotherapy for oncological indicationsNorma Bloy, Jonathan Pol, Gwenola Manic, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 5, 2024
Isolation of Primary Mouse Hepatocytes and Non-Parenchymal Cells from a Liver with Precancerous LesionsFlavia Lambertucci, Omar Motiño, Maria Pérez-Lanzón, et al.
Autophagy|August 18, 2016
Autophagy induction for the treatment of cancerFederico Pietrocola, Jonathan Pol, Erika Vacchelli, et al.
Oncoimmunology|May 7, 2014
Trial Watch: DNA vaccines for cancer therapyJonathan Pol, Norma Bloy, Florine Obrist, et al.
The Journal of Infectious Diseases|June 6, 2008
Expression of defective hepatitis B virus particles derived from singly spliced RNA is related to liver diseasePatrick Soussan, Jonathan Pol, Florianne Garreau, et al.
Cell Reports|July 19, 2018
HDACi Delivery Reprograms Tumor-Infiltrating Myeloid Cells to Eliminate Antigen-Loss VariantsAndrew Nguyen, Louisa Ho, Samuel T Workenhe, et al.
Pageof 7